Ozempic Sulfur Burps: When to Call the Doctor

Does Ozempic Cause Sulfur Burps?

Belching is one of the gastrointestinal reactions the Ozempic label records, and the label states that semaglutide slows gastric emptying [1]. The label's pooled placebo-controlled trial data lists eructation at 0% on placebo, 2.7% on 0.5 mg and 1.1% on 1 mg, among reactions that occurred in under 5% of treated patients [1]. It does not record a sulfur smell separately.

How Belching Compares Across Doses

In the label's pooled data, eructation was more common on 0.5 mg (2.7%) than on 1 mg (1.1%) [1]. Overall gastrointestinal reactions were 32.7% on 0.5 mg and 36.4% on 1 mg versus 15.3% on placebo [1]. In the separate 40-week trial of 2 mg versus 1 mg, GI reactions were 34% versus 30.8% [1].

Signs That Matter More Than Belching

Severe or persistent stomach pain

The Ozempic label identifies persistent or severe abdominal pain, sometimes radiating to the back, which may or may not be accompanied by nausea or vomiting, as a possible sign of acute pancreatitis [1]. Acute pancreatitis, including fatal and nonfatal hemorrhagic or necrotizing cases, has been reported with GLP-1 receptor agonists including Ozempic [1].

Burping alongside that kind of pain does not change what the pain signals.

Vomiting that keeps fluids from staying down

The label's kidney warning concerns volume depletion. Postmarketing reports include acute kidney injury, in some cases requiring hemodialysis, and the majority were in patients with gastrointestinal reactions leading to dehydration such as nausea, vomiting or diarrhea [1]. The label asks for renal function monitoring in patients reporting reactions that could lead to volume depletion, especially during dosage initiation and escalation [1].

Severe gastrointestinal reactions

Severe gastrointestinal adverse reactions were reported in 0.4% of patients on 0.5 mg and 0.8% on 1 mg, versus 0% on placebo [1]. Postmarketing reports listed in the Ozempic label include ileus, intestinal obstruction, and severe constipation with fecal impaction [1]. The label states that Ozempic is not recommended in patients with severe gastroparesis; it does not say the drug causes gastroparesis [1].

Gallbladder symptoms

Acute gallbladder disease is a labelled warning. If gallstones or cholecystitis are suspected, the label says gallbladder studies are indicated [1].

Dose Steps and Timing

Ozempic starts at 0.25 mg once weekly for 4 weeks, then 0.5 mg, with increases to 1 mg and then 2 mg at intervals of at least 4 weeks [1]. The 0.25 mg starting dose is not a maintenance dose [1].

Most reports of nausea, vomiting and diarrhea occurred during dose escalation [1]. The label gives no duration for belching.